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Affinity labelling of E. coli ribosomes with the 2’,3’-0-[4-(N-2-chloroethyl)-N-methylamino]benzylidene de- 
rivative of AUGU, was studied within the initiation complex (complex I) obtained by using Net-tRNArMe’ 
and initiation factors and within the pretranslocational complex (complex II) obtained by treatment of com- 
plex I with the ternary complex Phe-tRNA Ph’.GTP.EF-Tu. Both proteins and rRNA of 30 S as well as 50 
S subunits were found to be labelled. Sets of proteins labelled within complexes I and II differ considerably. 
Within complex II, proteins S13 and LlO were labelled preferentially. On the other hand, within complex 
I, multiple modification is observed (proteins S4, S12, Sl3, S14, S15, S18, S19, S2O/L26 were found to be 
alkylated) despite the single fixation of a template in the ribosome by interaction of the AUG codon with 
fMet-tRNArMet. 
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1. INTRODUCTION 
Previously, investigation of the structural 
organization of the mRNA-binding center of E. 
coli ribosomes was performed by using 
oligouridilate derivatives bearing different reactive 
groups attached to either the 3 ‘- or 5 ‘-end of the 
oligonucleotide moiety [l--S]. In first investiga- 
tions, deacylated tRNAPhe was used and it is clear 
now that it occupied preferentially the P-site [6,7]. 
Multiple modification of the ribosomes within the 
complexes with mRNA analogs and tRNAPhe was 
observed in [l-4]. Direct crosslinking between 
heptauridilate and E. coli ribosomes caused by a 
water-soluble carbodiimide within a complex with 
a vacant A-site and a complex stabilized by codon- 
anticodon interaction at both the A- and P-sites 
has been studied [5]. It was shown that one of the 
causes of the multiple modification is the lack of 
Pretranslocational complex 
codon-anticodon interaction at the A-site. Highly 
selective modification was observed within the 
complexes stabilized by codon-anticodon interac- 
tion at both A- and P-sites [5]. The other cause of 
the multiple modification is probably concerned 
with the multiplicity of location of the 
oligouridilate derivative in the ribosomal decoding 
site. For example, for oligouridilate derivatives 
containing more than 3 nucleotide residues with 
codon-anticodon interaction at the P-site only, as 
well as for derivatives containing more than 6 
nucleotide residues with codon-anticodon interac- 
tion at both A- and P-sites, one can propose the 
formation of several types of complexes differing 
in the location of a reactive group towards the 
ribosome. Recently, we have proposed the use of 
benzylidene derivatives of oligoribonucleotides 
containing initiation codon AUG at their 5 ‘-end 
for studying ribosomal components interacting 
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with a template at different steps of translation [8]. 3. RESULTS 
Here, we have investigated affinity labelling of 
E. coli ribosomes with the 2’ ,3 ’ -O-[4-(N-2-chlo- 
roethyl)-N-methylamino]benzylidene d rivative of 
AUGU6 both within the ribosomal initiation com- 
plex obtained by use of fMet-tRNAfMe’ and initia- 
tion factors and within the pretranslocational com- 
plex obtained by treatment of the initiation com- 
plex with the ternary complex Phe-tRNAPhe -
GTP. EF-Tu to occupy the A-site. Selective label- 
ling of proteins S13 and LlO was observed within 
the pretranslocational complex. On the other 
hand, within the initiation complex with a vacant 
A-site, despite the unequivocal fixation of mRNA 
analog in the ribosome, a rather large set of 
modified proteins was found. 
2. MATERIALS AND METHODS 
tRNAfMef and tRNAPhe were purchased from 
Boehringer Mannheim; unfractionated tRNA 
from E. coli and elongation factors EF-Tu .Ts 
from Soyuzreactive (USSR). tRNA enriched up to 
30% in tRNAye’ was isolated according to [9]. 
[3H]Methionine (spec. act. 15 Ci/mmol) was from 
Amersham; [‘4C]phenylalanine from UVVVR 
(Czechoslovakia); fMet-tRNAfMe’ (1200 pmol/&,o 
unit) and Phe-tRNAPhe (1500 pmol/&o unit) 
were prepared as in [8]. Ribosomal subunits were 
isolated from E. coli MRE-600 as in [IO]. 
Ribosomes obtained by reassociation of 30 S and 
50 S subunits had 100% activity in poly(U)- 
dependent binding of Phe-tRNAPhe. Initiation fac- 
tors IFl, IF2 and IF3, ribooligonucleotide AUGU6 
and its 2’,3’-O-[4-(N-2-chloroethyl)-N-methyl- 
aminolbenzylidene derivative (AUGU&HRCl) 
with specific activity 25 Ci/mol were prepared as 
in [8]. The ribosomal initiation complex 70 S 
ribosome * fMet-tRNAfMet . AUGU&HRCl (or 
AUGQ,) was obtained as in [8] and the ternary 
complex EF-Tu . GTP . Phe-tRNAPhe according to 
[ll]. Formation of fMetPhe after treatment of the 
initiation complex fMet-tRNA .70 S ribosome .
AUGU&HRCl with the ternary complex EF- 
Tu . GTP - Phe-tRNAPhe was tested according to 
[12]. Buffer A (pH 7.4) contained 50 mM Tris- 
HCI, 50 mM NH&l, 5 mM MgCl2, 1 mM dithio- 
threitol; buffer B (pH 7.5) comprised 50 mM Tris- 
HCl, 100 mM NH4Cl, 0.5 mM MgC12. 
To obtain the initiation complex mixture of 
16.2 nmol of 30 S subunits, 15.8 nmol of 50 S 
subunits, 160 nmol of [i4C]AUGU&HRCl, 
20 nmol fMet-tRNAPe’, 14Opg IFl, 220pg IF2, 
180 yg IF3 and 2 pmol GTP were incubated in 
10 ml buffer A at 37°C for 10 min. This resulted 
in the formation of the complex ribosome -
[‘4C]AUGU&HRCl - fMet-tRNA?” (complex I). 
To evaluate the level of binding of fMet-tRNAfMe’ 
with ribosomes in a separate xperiment complex I 
was obtained using [3H]fMet-tRNA?e’. It was 
found that 0.33 mol fMet-tRNAfMet was bound per 
mol 70 S ribosomes. In another experiment 18 
nmol Phe-tRNAPhe in the form of a ternary com- 
plex with EF-Tu and GTP was added to complex 
I and the mixture incubated at 37°C for 10 min. 
To determine the level of Phe-tRNAPhe binding in 
a parallel experiment the same complex was ob- 
tained using unlabelled fMet-tRNAfMe’ and 
[‘4C]Phe-tRNAPhe. The level of Phe-tRNAPhe 
binding was found to be 0.30 mol per mol 70 S 
ribosomes. Occupation of the A-site with Phe- 
tRNAPhe directed by EF-Tu and GTP resulted in 
transpeptidation in 90% complexes as judged from 
experiments using either [3H]fMet-tRNAve’ and 
Phe-tRNAPhe or fMet-tRNAfMet and [i4C]Phe- 
tRNAPhe. The data are listed in table 1. Transpep- 
tidation led to formation of the complex ri- 
bosome a [‘4C]AUGU,&HRCl - tRNA?“(P - site) . 
fMetPhe-tRNAPhe(A-site) designated as complex 
II. For affinity labelling of ribosomes complexes I
Formation of fMetPhe in pretranslocational complex II 
(30 pmol of 70 S ribosomes were taken in each 
experiment) 
Aminoacyl- 
tRNA 
f[3H]Met- 
tRNAP” 
Phe-tRNAPhC 
fMet-tRNATe’ 
[‘4C]Phe- 
tRNAPhe 
Table 1 
Binding (pmol) fMetPhe 
(pmol) 
f13H]Met- [14C]Phe- 
tRNAfMet tRNAPhe 
9.9 _ 8.4 
- 9.0 8.5 
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Table 2 
Extent of modification of the ribosomal subunits with 
[‘4C]AUGU&HRCl within complexes I and II (mol 
covalently attached reagent residues per mol subunit) 
Complex 
I 
II 
I 
AUGUj Extent of modification 
30 s 50 s 
- 0.095 0.025 
- 0.065 0.060 
+ 0.015 0.006 
and II were incubated at 37°C for 1 h (at this time 
35-40% of [14C]AUGU&HRCl is converted into 
a reactive intermediate ethyleneimmonium cation 
[ 131). After incubation ribosomes were separated 
into subunits by sucrose gradient (lo-40%) centri- 
fugation in 0.5 mM Mg2+ and the radioactivity 
bound to ribosomes was counted. The distribution 
of 14C label between the subunits is given in table 
2. In separate experiments complexes I and II 
were subjected to the same procedures in the pres- 
ence of a 50-fold excess of AUGU6 (over 
[14C]AUGU&HRC1) and with complex I in the 
absence of fMet-tRNA?. Covalent attachment of 
[14C]AUGU&HRCl was observed in both com- 
plex I and II. Both 30 S and 50 S subunits were 
labelled. Modification of 30 S and 50 S subunits 
within complexes I and II was inhibited practically 
in the presence of AUGU6. Thus, modification of 
both 30 S and 50 S subunits may be considered as 
affinity labelling. Both rRNA and proteins were 
modified, rRNA being labelled preferentially 
within complex I. Labelling of both rRNA and 
proteins was inhibited practically by a 50-fold 
molar excess of AUGU6 over the reagent (table 3). 
For identification of the labelled proteins they 
were extracted from ribosomes alkylated within 
complex I or II with 67% acetic acid. After 
hydrolysis of the benzylidene bond in the residues 
of covalently bound reagent, proteins were 
separated by two-dimensional polyacrylamide gel 
electrophoresis [ 11. The data are presented in fig. 1. 
It is seen that the results of modification of 
ribosomes within complexes I and II differ con- 
siderably. In the case of complex I, 8-9 proteins 
were labelled to a comparable extent whereas in 
complex II only proteins S13 and L 10 were labelled 
to a significant degree. In the control experiment 
with complex I carried out in the absence of fMet- 
tRNA?, no labelled proteins were found and 
radioactivity in the protein spots was no higher 
than 20-30 cpm (background values for this gel 
were 70-80 cpm). 
4. DISCUSSION 
Incubation of a complex of [‘4C]AUGU,jCHRCl 
with ribosomes bearing fMet-tRNAPe’ at the P-site 
or tRNApe’ at the P-site and fMetPhe-tRNAPhe at 
the A-site (complexes I and II, respectively) results 
in covalent attachment of AUGU&HRCl to 
ribosomes. The level of modification is rather 
high. In complex I as well as in complex II, 80% 
of the bound reagent is consumed in the alkylation 
of ribosomes (taking into account the extent of 
conversion of the reagent into the reactive in- 
Table 3 
Relative modification extents of proteins and rRNA from ribosomal subunit: 
modified with [‘4C]AUGU&HRCl within complexes I and II 
Complex Subunit Amount of radioactivitya (cpm) 
Proteins 
- AUGU6 + AUGU6 
rRNA 
- AUGU,j + AUGU6 
I 30 s 1200 180 3000 450 
I 50 s 100 50 900 150 
II 30 s 1930 - 1380 - 
II 50 s 2460 - 660 - 
a Assigned to 1000 pmol of the subunit in each case 
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a b 
514 
‘IjmJ&If~ 
5 10 15 20 5 10 15 20 
Proteln number 
b 
Proteln number 
Fig. 1. Distribution of label among the ribosomal protein 
modified AUGU&HRCl within initiation (a) and 
pretranslocational (b) complexes. 
termediate [ 131). As is evident from the competi- 
tion experiments between free AUGU6 and 
AUGU,jCHRCI, labelling of proteins and rRNA in 
both 30 S and 50 S ribosomal subunits is specific. 
The sets of ribosomal proteins labelled within com- 
plexes I and II differ significantly. In complex I 
(A-site vacant) a number of proteins are found to 
be labelled: S4, S12, S13, S14, S15, S18, S19, 
S2O/L26. In complex II (both A- and P-sites oc- 
cupied) proteins S 13 and LlO are labelled preferen- 
tially. Protein S13 is found in the set of proteins 
labelled within complex I whereas proteins LlO 
and L7/L12 were not labelled in complex I. 
Hence, in spite of the fact that AUGU&HRCl 
is definitely fixed in the ribosome by interaction of 
the AUG codon with fMet-tRNAfMe’ (in contrast to 
previously used mRNA analogs - derivatives of 
oligouridilates [l-5]) the set of proteins labelled in 
the 30 S subunit within the 70 S initiation complex 
is rather large. This may be due to the fact that the 
reactive group of the reagent is not strictly fixed 
towards the ribosome because of a rather long free 
moiety of the reagent which is not fixed in the 
ribosome by the codon-anticodon interaction. 
Stabilization of this complex by the additional 
codon-anticodon interaction at the A-site reduces 
the ‘free’ oligonucleotide moiety of the reagent 
which results in increased selectivity of modifica- 
tion. Hence, the existence of the codon-anticodon 
interaction at the A-site is of decisive significance 
for the correct localization of oligoribonucleo- 
tides, both homogeneous [5] and bearing an initia- 
tion codon at the 5 ‘-end in the decoding center. 
Systematic study of the mRNA-binding center 
of E. coli ribosomes was previously performed in 
a nonenzymatic system using alkylating derivatives 
of oligouridilates bearing the p-N-2-chloroethyl-N- 
methylaminophenyl group (RCI) attached to either 
the 3 ’ - or 5 ‘Lend [ 1,2]. In most cases a large 
amount of proteins is labelled. In some cases 
significant changes are observed when the 
oligouridilate moiety is elongated by only one 
uridilate residue. Proteins S4, S13, S14, S15 and 
S18 which were found to be labelled with 
AUGUjCHRCl were found previously to be la- 
belled with p(Up)II-iUCHRCl [l]; proteins S4, S13 
and S19 were also labelled with ClRCHzNH(pU), 
[2]. Moreover, proteins S4, S12, S13 and S18 were 
found by Pongs et al. [14] in the decoding region 
from affinity labelling studies with the use of an 
analog of the initiation codon AUG with a reactive 
group at the 5’-end. However, the existence of 
multiple labelling in the case of the derivatives of 
oligonucleotides [1,2,14], as well as for 
AUGUjCHRCl in complex I, hampers the assign- 
ment of some definite proteins to the decoding 
region. Nevertheless, the labelling of protein S13 in 
complex II is in good agreement with other data in- 
dicating that S13 belongs to the decoding region 
[ 15,161. Hence, in the course of investigation of af- 
finity labelling of ribosomes with tRNAPhe 
derivatives bearing an arylazido group on a 
guanine residue it was shown that labelling of the 
single protein S13 takes place in the presence of 
poly(U) whereas labelling of proteins S5, S9, Sl 1, 
S12, S19 and S21 proceeds when the tRNAPhe 
derivative is bound to the ribosome in either the 
presence or absence of poly(U) [ 151. Besides, it was 
shown previously that the binary complex 
poly(U) . S 13 possesses a strongly expressed ability 
of codon-selective binding of tRNA. The affinity 
of tRN.APhe to the binary complex poly(U) - S13 is 
about 3 orders of magnitude higher than for 
poly(U) alone [16]. 
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